Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
05/2003
05/21/2003EP1311516A1 Novel amidite derivatives for synthesising polymers on surfaces
05/21/2003EP1311282A1 High affinity integrin polypeptides and uses thereof
05/21/2003EP1230340A4 Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices
05/21/2003EP1125945B1 Reversible photocoupling nucleic acid and phosphoroamidite
05/21/2003EP0820285B1 Methods and compositions for lipidization of hydrophilic molecules
05/21/2003EP0411031B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
05/21/2003CN1418947A Application of benzimidazol resistance gene in trichodermin
05/21/2003CN1109043C 角质形成细胞生长因子－2 Keratinocyte growth factor-2
05/20/2003US6566515 Performing photochemical reactions on a surface; prepare chemical mixture, apply to surface, irradiate, monitor generation of reaction product
05/20/2003US6566514 Antisense oligonucleotides for use in the treatment of tumors
05/20/2003US6566495 Biosynthesis of preferential biopolymers; provide substrate, electrically activate preferential positions, bind monomer, repeat, recover biopolymers
05/20/2003US6566343 High affinity nucleic acid ligands of complement system proteins
05/20/2003US6566328 Administering to the patient a therapeutically effective amount of a polypeptide for therapy of patient in need of agonist effect of human growth hormone
05/20/2003US6566127 Enzymatic nucleic acid for use in the treatment of tumors, vision defects, arthritis and skin disorders
05/20/2003US6566116 Enzymatic polypeptide for use in the treatment of diabetic nephropathy, glomerulonephritis, fibrosis, liver and kidney disorders, osteoporosis and lung disorders
05/20/2003US6566093 Alphavirus cDNA vectors
05/20/2003US6566092 Nucleotide sequences coding polypeptide for use in the treatment nervous system disorders
05/20/2003US6566082 T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions
05/20/2003US6566071 Useful as fluorescent labeling reagents
05/20/2003US6566070 Detecting preferential protein biosynthesis; label nucleotide sequences, mix with translation system, incubate, detct signal from protein
05/20/2003US6566068 Process for detecting a nucleic acid of interest using an oligo- or polynucleotide probe and intercalators
05/20/2003US6566059 Detecting variability in a nucleotide sequence; obtain nucleotide sequences, replace nucleic acids, cleave sequences, analyze sequences and detect variance in genotypes
05/20/2003US6566053 Diagnosing tumors in humans; obtain sample, extract nucleotide sequences, incubate with probe, detect hybridization to microsatellite sequences, presence of microsattelite sequences indicates cancer
05/20/2003US6565789 Methods for producing low binding surfaces
05/20/2003CA2199515C Automated molecular biological diagnostic system
05/20/2003CA2197302C Solid support reagents for the synthesis of 3'-nitrogen containing polynucleotides
05/15/2003WO2003040726A2 Screening for hepatitis c virus entry inhibitors
05/15/2003WO2003040689A2 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
05/15/2003WO2003040687A2 Isolation and purification of nucleic acids
05/15/2003WO2003040414A1 Method and device for detecting and monitoring alcoholism and related diseases using microarrays
05/15/2003WO2003040410A1 Detection of hybridization oligonucleotide microarray through covalently labeling microarray probe
05/15/2003WO2003040409A1 Novel germinal center kinase proteins, compositions, and methods of use
05/15/2003WO2003040400A2 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids
05/15/2003WO2003040395A2 Universal nucleotides for nucleic acid analysis
05/15/2003WO2003040364A1 Method for the isolation of nucleic acids
05/15/2003WO2003040344A2 Transcription factor stress-related polypeptides and methods of use in plants
05/15/2003WO2003040322A2 Promoters for regulation of gene expression in plant roots
05/15/2003WO2003040295A2 Ion channel
05/15/2003WO2003040183A2 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
05/15/2003WO2003040181A2 Genes from the corynebacterium glutamicum coding for regulatory proteins
05/15/2003WO2003039523A2 OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
05/15/2003WO2003039476A2 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874
05/15/2003WO2003039404A2 Methods for treating ocular neovascular diseases
05/15/2003WO2003039346A2 Diagnostics and therapeutics for ocular abnormalities
05/15/2003WO2002061130A3 Methods and reagents for analysis of rna structure and function
05/15/2003US20030092904 Immobilization of nucleotide monomers in a microarray; dissolve nucleotide monomer, oligonucleotide, or polynucleotide in a solvent, expose insoluble substrate with solution, imobilize biopolymers, recover microarray
05/15/2003US20030092901 Preparation of oligonucleotide-protein conjugate; obtain oligonucleotide expose to linker, join, expose oligonucleotide-linker conjugate with preferential protein, join, recover oligonucleotide-protein conjugate
05/15/2003US20030092886 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders
05/15/2003US20030092883 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer and nervous system disorders
05/15/2003US20030092655 Delivery system for nucleic acids
05/15/2003US20030092647 Antisense modulation of cholesteryl ester transfer protein expression
05/15/2003US20030092615 Nucleic acids, proteins, and antibodies
05/15/2003US20030092611 Nucleic acids, proteins, and antibodies
05/15/2003US20030092147 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092122 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092121 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092115 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092113 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092112 Novel nucleic acids and polypeptides
05/15/2003US20030092111 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092110 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092108 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092107 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092106 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092105 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092104 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders
05/15/2003US20030092103 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030092102 Nucleic acids, proteins, and antibodies
05/15/2003US20030092101 Human tumor necrosis factor receptors TR13 and TR14
05/15/2003US20030092061 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferation and tumor disorders
05/15/2003US20030092046 Monomer for use in huaman therapeutics and diagnostics
05/15/2003US20030092045 Binding nucleotide sequences to cellulose; obtain cellulose, mix with solution, adjust sample and polyethylene glycol concentration, recover bound nucleotide sequenes
05/15/2003US20030092018 Cloned DNA polymerases from thermotoga neapolitana
05/15/2003US20030092006 Classification of preferential nucleotide sequences; obtain nucleotide sequences, insert into vector, transform cells, generate clones, generate ribonucleic acid from clones, divide sequences, amplify and measure sequence concentration
05/15/2003US20030092003 Nucleic acid sensor molecule which modulates expression of amyloid precursor proteins cleaving enzyme; for use in the treatment of nervous system disorders
05/15/2003US20030092002 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/15/2003US20030091999 Nucleotide sequences coding complex for use in treatment of cancer and viral disease
05/15/2003US20030091594 CD4-independent HIV envelope proteins as vaccines and therapeutics
05/15/2003US20030091476 Comprises microscopic vessels; for microarrays of DNA and RNA oligonucleotides, peptides, oligosacchrides, and phospholipids; genetic mapping; drug screening
05/15/2003CA2789407A1 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003CA2782864A1 Compositions from the grasses lolium perenne and festuca arundinacea
05/15/2003CA2736469A1 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
05/15/2003CA2465961A1 Isolation and purification of nucleic acids
05/15/2003CA2465951A1 Transcription factor stress-related polypeptides and methods of use in plants
05/15/2003CA2465731A1 Screening for hepatitis c virus entry inhibitors
05/15/2003CA2464007A1 Methods for treating ocular neovascular diseases
05/14/2003EP1310558A2 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
05/14/2003EP1310555A2 Oligonucleotide modulation of protein kinase C
05/14/2003EP1310507A2 Novel peptide nucleic acids
05/14/2003EP1309730A2 New hydrazide building blocks and hydrazide modified biomolecules
05/14/2003EP1309727A2 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease
05/14/2003EP1309726A2 Rna sequence-specific mediators of rna interference
05/14/2003EP1309525A2 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries
05/14/2003EP0990047B1 Methods and compositions for analyzing nucleic acids by mass spectrometry
05/14/2003EP0874912A4 Multiparametric fluorescence in situ hybridization
05/14/2003EP0666929B1 Method of inhibiting replication of hyperproliferative cells
05/14/2003EP0666919B1 Vaccine containing a thiol protease
05/14/2003CN1417331A Biological steel gene and its encoded protein
05/14/2003CN1417330A Meltiple antigenic compound Bt gene and its application in plant
05/14/2003CN1417329A Polyepitope malaria vaccine and its encoding gene
1 ... 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 ... 899